Evidence map›Paper›PMID 34378948›Full record

ArticleMicrobiology spectrum2021

Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.

Aya Ishizaka, Michiko Koga, Taketoshi Mizutani, Prince Kofi Parbie, Diki Prawisuda, Nozomi Yusa, Ayako Sedohara, Tadashi Kikuchi, Kazuhiko Ikeuchi, Eisuke Adachi and 9 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 2 pooled it
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Aya IshizakaDivision of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Michiko KogaDivision of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Taketoshi MizutaniDivision of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Prince Kofi ParbieAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Diki PrawisudaDivision of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Nozomi YusaDepartment of Applied Genomics, Research Hospital, Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Ayako SedoharaDivision of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Tadashi KikuchiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kazuhiko IkeuchiDepartment of Infectious Diseases and Applied Immunology, IMSUT Hospital of Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Eisuke AdachiDepartment of Infectious Diseases and Applied Immunology, IMSUT Hospital of Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Tomohiko KoibuchiDepartment of Infectious Diseases and Applied Immunology, IMSUT Hospital of Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Yoichi FurukawaDepartment of Applied Genomics, Research Hospital, Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Arinobu TojoDepartment of Laboratory Medicine, Research Hospital, Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Seiya ImotoDivision of Health Medical Data Science, Health Intelligence Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Yutaka SuzukiDepartment of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyogrid.26999.3d, Chiba, Japan.
Takeya TsutsumiDivision of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Hiroshi KiyonoInternational Research and Development Center for Mucosal Vaccines, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Tetsuro MatanoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0003-3096-6749
Hiroshi YotsuyanagiDivision of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyogrid.26999.3d, Tokyo, Japan.
The University of Tokyo · JPUniversity of Tokyo Hospital · JPNational Institute of Infectious Diseases · JPTokyo Medical University Hospital · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic inflammation is a hallmark of human immunodeficiency virus (HIV) infection and a risk factor for the development and progression of age-related comorbidities. Although HIV-associated gut dysbiosis has been suggested to be involved in sustained chronic inflammation, there remains a limited understanding of the association between gut dysbiosis and chronic inflammation during HIV infection. Here, we investigated compositional changes in the gut microbiome and its role in chronic inflammation in patients infected with HIV. We observed that the gut microbiomes of patients with low CD4 counts had reduced alpha diversity compared to those in uninfected controls. Following CD4 recovery, alpha diversity was restored, but intergroup dissimilarity of bacterial composition remained unchanged between patients and uninfected controls. Patients with HIV had higher abundance of the classes

Indexed as

Gastrointestinal MicrobiomeAdultAnti-HIV AgentsBacteriaCD4-Positive T-LymphocytesChronic DiseaseDysbiosisFemaleGastrointestinal TractHIV InfectionsHumansMaleMiddle AgedAnti-HIV AgentsdysbiosisHIVhuman immunodeficiency virusinflammationmicrobiomemicrobiota

Identifiers

PMID34378948
PMCPMC8552706
OpenAlexW3193091415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.